Cited by 667Respiratory Support and MechanismsNeonatal Respiratory Health ResearchNosocomial Infections in ICU

Noninvasive Ventilation of Patients with Acute Respiratory Distress Syndrome. Insights from the LUNG SAFE Study

Open access
Bellani, Giacomo, Laffey, John G., Pham, Tài, Madotto, Fabiana, Fan, Eddy, Brochard, Laurent, Esteban, Andres, Gattinoni, Luciano +14 more·2017·American Journal of Respiratory and Critical Care Medicine

Abstract

Rationale: Noninvasive ventilation (NIV) is increasingly used in patients with acute respiratory distress syndrome (ARDS). The evidence supporting NIV use in patients with ARDS remains relatively sparse. Objectives: To determine whether, during NIV, the categorization of ARDS severity based on the PaO2/FiO2 Berlin criteria is useful. Methods: The LUNG SAFE (Large Observational Study to Understand the Global Impact of Severe Acute Respiratory Failure) study described the management of patients with ARDS. This substudy examines the current practice of NIV use in ARDS, the utility of the PaO2/FiO2 ratio in classifying patients receiving NIV, and the impact of NIV on outcome. Measurements and Main Results: Of 2,813 patients with ARDS, 436 (15.5%) were managed with NIV on Days 1 and 2 following fulfillment of diagnostic criteria. Classification of ARDS severity based on PaO2/FiO2 ratio was associated with an increase in intensity of ventilatory support, NIV failure, and intensive care unit (ICU) mortality. NIV failure occurred in 22.2% of mild, 42.3% of moderate, and 47.1% of patients with severe ARDS. Hospital mortality in patients with NIV success and failure was 16.1% and 45.4%, respectively. NIV use was independently associated with increased ICU (hazard ratio, 1.446 [95% confidence interval, 1.159–1.805]), but not hospital, mortality. In a propensity matched analysis, ICU mortality was higher in NIV than invasively ventilated patients with a PaO2/FiO2 lower than 150 mm Hg. Conclusions: NIV was used in 15% of patients with ARDS, irrespective of severity category. NIV seems to be associated with higher ICU mortality in patients with a PaO2/FiO2 lower than 150 mm Hg. Clinical trial registered with www.clinicaltrials.gov (NCT 02010073).

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1164/rccm.201606-1306oc

Cites

33 of 33 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Evidence shows higher blood pressure at early and later time points, higher static filling pressures, and lower net fluid balance with albumin.

    “The suggestion to consider albumin in patients who received large volumes of crystalloids is informed by evidence showing higher blood pressure at early and later time points (339), higher static filling pressures (340), and lower net fluid balance (339) with albumin.”

    From Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2021. (2021) · cites this paper as [339]

    Citation 340 is attached specifically to the claim of higher static filling pressures with albumin. The ORIGINAL ARTICLE tables (pp. 8 and 10) report respiratory and ventilation measures, not an albumin comparison or static filling pressures. Searches for those terms and for albumin, crystalloids, fluid balance, and blood pressure found no passage addressing that claim. (LLM, conf=0.77)

    Experimental — accuracy not yet measured
  • Albumin is theoretically more likely to maintain oncotic pressure than crystalloids, but it is more costly and there is no clear benefit with its routine use.

    “Although albumin is theoretically more likely to maintain oncotic pressure than crystalloids (339), it is more costly and there is no clear benefit with its routine use.”

    From Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2021. (2021) · cites this paper as [339]

    The citation is attached to the claim that albumin is more likely than crystalloids to maintain oncotic pressure. Our copy discusses noninvasive ventilation in ARDS (What This Study Adds, p. 3; Discussion, p. 7), but the passages returned for searches on albumin, crystalloids, oncotic pressure, cost, and routine use do not address that comparison. (LLM, conf=0.77)

    Experimental — accuracy not yet measured
  • The ALBIOS trial comparing albumin plus crystalloids to crystalloids alone in 1,818 patients with sepsis or septic shock did not demonstrate a difference in 28-day (RR, 1.0; 95% CI, 0.87-1.14) or 90-day mortality (RR, 0.94; 95% CI, 0.85-1.05).

    “The largest clinical trial in sepsis, the ALBIOS trial comparing a combination of albumin and crystalloids to crystalloids alone in 1,818 patients with sepsis or septic shock did not demonstrate a difference in 28-day (RR, 1.0; 95% CI, 0.87-1.14)or 90-day mortality (RR, 0.94; 95% CI, 0.85-1.05)(339).”

    From Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2021. (2021) · cites this paper as [339]

    Split into 2 atoms — 0 confirmed, 0 partially supported, 0 disputed, 0 misattributed, 2 unverifiable. Expand the claim to see per-atom verdicts.

    Experimental — accuracy not yet measured
  • The LUNG SAFE trial demonstrated that NIV was used in 15% of patients with ARDS with varying failure and mortality rates, depending on ARDS severity.

    “For example, the LUNG SAFE trial demonstrated that NIV was used in 15% of patients with ARDS with varying failure and mortality rates, depending on ARDS severity [417].”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Bellani, G., Laffey, J. G., Pham, T., Madotto, F., Fan, E., Brochard, L., Esteban, A., Gattinoni, L., Bumbasirevic, V., Piquilloud, L., van Haren, F., Larsson, A., McAuley, D. F., Bauer, P. R., Arabi, Y. M., Ranieri, M., Antonelli, M., Rubenfeld, G. D., Thompson, B. T., Wrigge, H., Slutsky, A. S., & Pesenti, A.
Affiliations
  • Azienda Ospedaliera San Gerardo (IT)
  • St. Michael's Hospital (CA)
  • Inserm (FR)
  • University of Milano-Bicocca (IT)
  • Mount Sinai Hospital (CA)
  • Centro de Investigación Biomédica en Red de Enfermedades Respiratorias (ES)
  • Universitätsmedizin Göttingen (DE)
  • School of Medicine, University of Belgrade, Belgrade, Serbia
  • Centre Hospitalier Universitaire Vaudois (CH)
  • Intensive Care Unit, The Canberra Hospital, Canberra, Australia
  • Uppsala University (SE)
  • Queen's University Belfast (GB)
  • Mayo Clinic (US)
  • King Saud bin Abdulaziz University for Health Sciences (SA)
  • Dipartimento di Anestesia e Rianimazione, Policlinico Umberto I, Sapienza Università di Roma, Roma, Italy
  • Università Cattolica del Sacro Cuore (IT)
  • Sunnybrook Health Science Centre (CA)
  • Harvard University (US)
  • University Hospital Leipzig (DE)
  • University of Milan (IT)
Corresponding author
Laffey, John G.
Venue
American Journal of Respiratory and Critical Care Medicine
Published
2017-01-01
Volume
195
Issue
1
Pages
67-77
ISSN
  • 1073-449X (ISSN-L)
  • 1535-4970
OpenAlex
W2536303762
Cited by
667
References
33
Citations by year
2026: 47 · 2025: 37 · 2024: 54 · 2023: 75 · 2022: 105 · 2021: 129 · 2020: 97 · 2019: 43 · 2018: 44 · 2017: 33
FWCI
35.75
Type
journal article
Language
en
Open access
Locations
  • American Journal of Respiratory and Critical Care Medicine (publishedVersion)
  • PubMed (publishedVersion)
  • Research Portal (Queen's University Belfast) (publishedVersion, other-oa)
  • Institutional Research Information System University of Turin (University of Turin) (submittedVersion, other-oa)
  • Pure Amsterdam UMC (submittedVersion, other-oa)
  • Data Archiving and Networked Services (DANS) (submittedVersion)
  • BOA (University of Milano-Bicocca) (submittedVersion)
  • Archivio istituzionale della ricerca (Alma Mater Studiorum Università di Bologna) (submittedVersion)
  • DIAL (Catholic University of Leuven) (submittedVersion)
  • Archivio Istituzionale della Ricerca - Università degli Studi della Campania "Luigi Vanvitelli" (submittedVersion)
  • Institutional Research Information System University of Ferrara (University of Ferrara) (submittedVersion, other-oa)
  • IRIS (submittedVersion)
  • Nova Science Publishers (Nova Science Publishers, Inc.) (submittedVersion, other-oa)
  • Archivio Istituzionale della Ricerca - Università Vita-Salute San Raffaele (submittedVersion)
  • UnissResearch (Università degli Studi di Sassari) (submittedVersion)
  • ANU Open Research (Australian National University) (submittedVersion)
  • CINECA IRIS Institutional Research Information System (University of Bari Aldo Moro) (submittedVersion)
  • SERVAL (Université de Lausanne) (submittedVersion)
Funders
  • Università degli Studi di Milano
  • European Society of Intensive Care Medicine
Topics
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Respiratory Support and Mechanisms
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Neonatal Respiratory Health Research
  • Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Nosocomial Infections in ICU
Keywords
non-invasive ventilation, acute respiratory distress syndrome, PaO2/FiO2 ratio, Berlin criteria, ARDS severity classification, NIV failure, ICU mortality, in-hospital mortality, invasive mechanical ventilation, acute respiratory failure
MeSH terms
Aged, Female, Humans, Intensive Care Units, Male, Middle Aged, Respiratory Distress Syndrome, Severity of Illness Index, Treatment Outcome, Hospital Mortality, Noninvasive Ventilation

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review